A serious illness doesn’t just attack your health.
It attacks your income.
- Your mortgage.
- Your business.
- Your long-term plans.
And it rarely gives notice.
At Broadbench, we regularly meet intelligent, successful individuals and business owners who have pensions, investments and growth strategies in place, yet have left the most immediate financial threat exposed.
Critical Illness Cover (CIC) is not about pessimism.
It’s about preparedness.
The Reality Few People Want to Talk About
Medical advances mean more people survive serious illnesses. That’s good news.
But survival often comes with:
- Months (or years) off work
- Reduced earning capacity
- Expensive treatment options
- Business disruption
- Lifestyle adjustments
Statistically, working-age adults are far more likely to suffer a critical illness than to die prematurely. Yet life cover is often prioritised over CIC.
Why?
Because illness feels uncomfortable to discuss.
Financial damage, however, is very real.
What Critical Illness Cover Actually Does
Critical Illness Cover pays a tax-free lump sum on diagnosis of specified serious conditions, such as:
- Cancer
- Heart attack
- Stroke
- Major organ failure
- Multiple sclerosis
This is not a monthly drip feed.
It is a meaningful capital injection at the exact moment your financial world could otherwise start to unravel.
You decide how it is used:
- Clear the mortgage
- Remove business debt
- Replace lost income
- Fund private treatment
- Adapt your home
- Create breathing space
Breathing space is underrated until you need it.
The Hidden Risk for Business Owners
For directors and shareholders, critical illness isn’t just personal.
It’s corporate.
If a key individual becomes critically ill, the business may face:
- Immediate loss of revenue
- Client uncertainty
- Staff disruption
- Recruitment costs
- Pressure from lenders
Key Person Critical Illness Cover
Provides capital to stabilise the company while a key individual recovers — or to fund a structured transition.
Shareholder / Business Protection with CIC
If a shareholder becomes critically ill, they may wish to step away.
Without planning, that creates:
- Valuation disputes
- Cashflow pressure
- Ownership instability
With properly structured cover, remaining shareholders can purchase shares cleanly and fairly — protecting both the business and the affected owner’s family.
Illness should not trigger commercial chaos.
The Dangerous Myth: “All Policies Are the Same”
They are not.
Differences can include:
- Definitions of “cancer” (yes, this matters)
- Number of covered conditions
- Partial vs full payouts
- Survival periods
- Guaranteed vs reviewable premiums
- Children’s cover and added-value services
A cheap policy that fails at the claim stage is not a saving. It is a liability disguised as prudence.
Why Broadbench Advisers Make the Difference
Protection planning is not about buying a product.
It is about designing resilience.
At Broadbench, we approach Critical Illness Cover strategically:
1. We Stress-Test Your Financial Plan
What happens if income stops tomorrow?
What happens if a shareholder exits due to illness?
We model scenarios before they happen.
2. We Compare the Whole Market
Strong definitions and claims performance matter more than headline premiums.
3. We Structure Cover Intelligently
For business owners, we consider:
- Tax efficiency
- Trust structures
- Cross-option agreements
- Alignment with wider succession planning
4. We Integrate – Not Duplicate
CIC must work alongside life cover, income protection, pensions and investments.
Gaps and overlaps both cost money.
5. We Review Regularly
Your income grows.
Your business evolves.
Your protection must keep pace.
The Hard Truth
Most people insure their phone within minutes of purchase.
Yet the income that pays for everything? Often left exposed.
A serious illness is not rare. Financial shock is avoidable.
Critical Illness Cover ensures that if health falters, your financial position does not collapse with it.
If you want to know whether your current protection would genuinely withstand a diagnosis, a structured review with a Broadbench adviser is a sensible place to start.
Hope is not a strategy.
Preparation is.
